ZAO Rafarma management recently met with senior faculty members of the St. Petersburg Academy of Pharmaceutical Chemistry to create a long-term cooperative agreement.
Rafarma will work with and be able to recruit from the finest pharmaceutical specialists graduating in Russia, as well as having access to the Academy’s innovative pharmaceutical research.
The cooperative agreement is borne out of the initiatives outlined in “Pharma 2020,” the Russian National Pharmaceutical Strategy. For the Academy, the agreement creates specialized and tailored educational programs allowing undergraduates exposure to Rafarma’s most innovative testing protocols at Rafarma’s state-of-the-art facilities under highly-skilled technical supervision.
“Such cooperative agreements with pharmaceutical higher education continue to raise Rafarma’s leadership position in the Russian pharmaceutical industry. We are delighted to have an institution of such extraordinary reputation as a partner,” said Rafarma’s CEO David Anderson.
Date: February 6, 2014
Source: Rafarma Pharmaceuticals
Filed Under: Drug Discovery